Adela Gállego

Is there a window of opportunity in the treatment of giant cell arteritis with tocilizumab? Multicenter study of 471 patients

Adrián Martín-Gutiérrez, Javier Loricera, Diana Prieto-Peña, Vicente Aldasoro et autres

es, lb (code pays fourni par la source)

PO:12:318 Belimumab in monotherapy: a subanalysis of the Spanish national registry of belimumab in systemic lupus eythematosus

Maria Elena Laino, Vicente Aldasoro, Mónica Enguita, Javier Loricera et autres

Objectives Background: Belimumab (BLM) is a monoclonal antibody that inhibits B-lymphocyte stimulating factor (BlyS), approved in 2011 as a treatment for systemic lupus erythematosus (SLE). We present the experience with BLM in monotherapy in this spanish cohort.Objectives To describe demographic characteristics, effectiveness …

es (code pays fourni par la source)

LSO-066 Spanish national regsitry of belimumab in patients with systemic lupus erythematosus

Vicente Aldasoro, Maria Elena Laino, Mónica Enguita, J. Loricera et autres

Background First multicenter study in clinical practice in SLE patients treated with BLM in Spain. Methods Descriptive, retrospective, multicenter study in patients diagnosed with SLE according to EULAR/ACR 2019, SLICC and/or ACR 1997 diagnostic criteria. Data regarding SLE patients treated with BLM …

es (code pays fourni par la source)